Life Science stocks got a boost from news and presentations at the J.P.Morgan Healthcare Conference and most stocks from the Rayno Life Science Portfolio were up.(see our “January Effect” trades mentioned in December). Leading life science tools companies Illumina (ILMN $34) up 3% again today,and Life Technologies (LIFE $46.28) were boosted by new product announcements, new markets for genetic testing like personalized medicine and consumer genomics and reduced concern over NIH budget cuts. More details tomorrow.
Biopharmaceutical stocks also continued to rally.